NCT05184114View on ClinicalTrials.gov

Clinical Significance of Subclinical Myocardial Involvement in Recovered COVID-19 Patients Using Cardiovascular Magnetic Resonance

NACompletedINTERVENTIONAL

Enrollment

162

Participants

Timeline

Start Date

October 4, 2021

Primary Completion Date

August 8, 2024

Study Completion Date

August 8, 2024

Conditions

COVID-19Myocarditis

Interventions

DIAGNOSTIC_TEST

Cardiac Magnetic Resonance, Blood Tests

Imaging, blood investigations (white cell count, C-reactive protein, NT-proBNP, lactate dehydrogenase and high sensitivity troponin)

Trial Locations (1)

Unknown

The University of Hong Kong, Hong Kong

All Listed Sponsors

lead

The University of Hong Kong

OTHER

NCT05184114 - Clinical Significance of Subclinical Myocardial Involvement in Recovered COVID-19 Patients Using Cardiovascular Magnetic Resonance | Biotech Hunter | Biotech Hunter